EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MSC Exosomes and Rutin‐Chitosan–Pectin Nanoparticles Synergize to Ameliorate Adjuvant Arthritis via Th1/Th2 Modulation, MMP Suppression, Nrf2 Upregulation, and Antioxidant Boost

Karim M Moftah iD, Walaa G Hozayen iD, Nabil A Hasona iD, Hessah M Al-Muzafar iD, Kamal A Amin iD, Hussah A Alshwyeh iD, Khairy M A Zoheir iD, Osama M Ahmed iD

Stem Cells International · 2026-01 · 2026 (1)

DOI: 10.1155/sci/3586025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells International, online erschienen am 03.04.2026. Verfasst von Karim M Moftah und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt, bsu.edu.eg. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Due to toxicity, high costs, and potential side effects of standard treatments of rheumatoid arthritis (RA) including nonsteroidal anti‐inflammatory drugs (NSAIDs), corticosteroids, and disease‐modifying antirheumatic drugs (DMARDs), natural products and advanced drug delivery systems, such as nanoparticles and mesenchymal stem cell (MSC)–derived exosomes (EXO), have garnered interest due to their ability to target inflammation and oxidative damage, with enhanced precision and reduced side effects, offering a promising approach for RA management.

Methods

EXO were isolated from the conditioned medium of bone marrow–derived MSCs (BM‐MSCs). Rutin (RT)‐loaded chitosan (Cs)/pectin nanoparticles were prepared using a modified ionic gelation technique to enhance stability and bioavailability. Sixty male Wistar rats were utilized in the in vivo experiment and randomly assigned to six groups, each comprising 10 animals. These groups were (1) normal control, (2) complete Freund’s adjuvant (CFA)‐induced arthritic control, (3) CFA‐induced arthritis treated with free RT (20 mg/kg), (4) CFA‐induced arthritis treated with EXO (100 µg protein per rat, intravenous injection, once weekly), (5) CFA‐induced arthritis treated with RT‐Cs–pectin nanocomposite (RT‐CPN) (20 mg/kg), and (6) CFA‐induced arthritis treated with a combination of RT‐CPN and EXO. Treatments were administered for 28 days, after which the rats were euthanized for further analysis. For molecular evaluations, blood was collected for serum isolation, and the right ankle joint was carefully dissected.

Results

Treatment with RT, EXO, RT‐CPN, and especially, EXO + RT‐CPN combination significantly reduced serum levels of anticitrullinated protein antibodies (ACPAs), interleukin‐1β (IL‐1β), interleukin‐6 (IL‐6), and the marker of oxidative stress malondialdehyde (MDA). These treatments also decreased inducible nitric oxide synthase (iNOS) mRNA expression, a key regulator of oxidative and inflammatory processes. Conversely, antioxidant defenses improved, as indicated by increased serum glutathione (GSH), interleukin‐10 (IL‐10), and interleukin‐13 (IL‐13) levels, along with upregulation of antioxidant enzymes such glutathione peroxidase (GPx), glutathione S‐transferase (GST), glutathione reductase (GR), and superoxide dismutase (SOD). Joint degradation was notably reduced by suppressing the protein levels of MMP‐1, MMP‐3, MMP‐9, and MMP‐13, while nuclear factor erythroid 2–related factor 2 (Nrf2) expression, a critical regulator of cellular protection, was elevated. Along with improvements in functional and molecular markers, the right hind leg’s swelling and redness decreased, and the histological alterations including pannus development, inflammatory cell infiltrations, synovial membrane hyperplasia, and degradation of articular cartilage were substantially suppressed after treatments.

Conclusions

The combination of EXO + RT‐CPN demonstrated the strongest antiarthritic effects, reducing inflammation, oxidative stress, and joint degradation while boosting the body’s antioxidant defenses. These findings highlight a promising, safer therapeutic strategy for RA management.

Schlagwörter

Stichwörter der Autor:innen

BM-MSCsantioxidantexosomesoxidative stressrutinrutin-chitosan-pectin nanoparticles

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt, bsu.edu.eg.
  • Department of Chemistry, College of Science, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia, iau.edu.sa.
  • Basic and Applied Scientific Research Center (BASRC), Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia, iau.edu.sa.
  • Department of Biology, College of Science, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia, iau.edu.sa.
  • Department of Cell Biology, Biotechnology Research Institute, National Research Centre, Cairo, Egypt, nrc.sci.eg.
  • Physiology Division, Department of Zoology, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt, bsu.edu.eg.

ORCID-Profile: Karim M Moftah, Walaa G Hozayen, Nabil A Hasona, Hessah M Al-Muzafar, Kamal A Amin, Hussah A Alshwyeh, Khairy M A Zoheir, Osama M Ahmed

Zitieren

APA

Moftah, K. M., Hozayen, W. G., Hasona, N. A., Al-Muzafar, H. M., Amin, K. A., Alshwyeh, H. A., Zoheir, K. M. A., & Ahmed, O. M. (2026). MSC Exosomes and Rutin‐Chitosan–Pectin Nanoparticles Synergize to Ameliorate Adjuvant Arthritis via Th1/Th2 Modulation, MMP Suppression, Nrf2 Upregulation, and Antioxidant Boost. Stem Cells International, 2026(1). https://doi.org/10.1155/sci/3586025

Vancouver

Moftah KM, Hozayen WG, Hasona NA, Al-Muzafar HM, Amin KA, Alshwyeh HA, et al. MSC Exosomes and Rutin‐Chitosan–Pectin Nanoparticles Synergize to Ameliorate Adjuvant Arthritis via Th1/Th2 Modulation, MMP Suppression, Nrf2 Upregulation, and Antioxidant Boost. Stem Cells International. 2026;2026(1). doi:10.1155/sci/3586025

BibTeX
@article{Moftah2026,
  author = {Moftah, Karim M and Hozayen, Walaa G and Hasona, Nabil A and Al-Muzafar, Hessah M and Amin, Kamal A and Alshwyeh, Hussah A and Zoheir, Khairy M A and Ahmed, Osama M},
  title = {MSC Exosomes and Rutin‐Chitosan–Pectin Nanoparticles Synergize to Ameliorate Adjuvant Arthritis via Th1/Th2 Modulation, MMP Suppression, Nrf2 Upregulation, and Antioxidant Boost},
  journal = {Stem Cells International},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/sci/3586025}
}
Kostenlos starten →